Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,087.60
-9.40 (-0.86%)
Sep 26, 2025, 1:44 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 637.14 billion as of September 25, 2025. Its market cap has decreased by -28.65% in one year.
Market Cap
637.14B
Enterprise Value
637.35B
Revenue
320.25B
Ranking
n/a
PE Ratio
18.81
Stock Price
1,087.60
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 637.14B, an increase of 6,534.61%. That is a compound annual growth rate of 19.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 633.60B | -18.25% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | 539.83B | 101.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,903.96B |
| Divi's Laboratories | 1,588.56B |
| Cipla | 1,242.33B |
| Apollo Hospitals Enterprise | 1,099.02B |
| Mankind Pharma | 1,044.16B |
| Zydus Lifesciences | 1,042.46B |
| Fortis Healthcare | 725.06B |
| Alkem Laboratories | 666.69B |